Medicine and Dentistry
Sickle-Cell Disease
100%
Blood Donor
40%
Prevalence
27%
Disease
22%
Blood Transfusion
22%
Maternal Mortality
18%
Leg Ulcer
17%
Perinatal Mortality
16%
Systematic Review
16%
Lupus Anticoagulant
15%
Serotype
15%
Hematology
14%
Mortality Rate
14%
Thrombosis
13%
Cohort Effect
11%
Study Participant
10%
Acute Chest Syndrome
9%
Antibiotic Resistance
9%
Antiphospholipid Antibody
9%
Blood Smear
9%
Thrombocytopenia
9%
Pain
9%
Low and Middle Income Countries
8%
Third Trimester Pregnancy
8%
Anemia
8%
Hypercoagulability
8%
Venous Thromboembolism
8%
Platelet
7%
Odds Ratio
7%
Awareness
7%
Niacin
7%
Hemoglobin SC Disease
7%
Ascorbic Acid
7%
Megaloblastic Anemia
7%
Neurofibromatosis Type I
7%
Meta-Analysis
7%
Chronic Myelogenous Leukemia
7%
Hypertension
7%
Chronic Myelogenous Leukemia
7%
Pulmonary Embolism
7%
Folic Acid
7%
Communicable Disease
7%
Cyanocobalamin
7%
Physician
7%
Vascularity
7%
Fetomaternal Transfusion
7%
Partial Thromboplastin Time
7%
Hydroxyurea
7%
Conjugate Vaccine
7%
Vulnerable Population
7%
Nursing and Health Professions
Lupus Anticoagulant
31%
Sickle Cell Anemia
25%
Blood Donor
16%
Venous Thromboembolism
15%
Human Immunodeficiency Virus
15%
Blood Transfusion
15%
Malignant Neoplasm
14%
Thrombosis
13%
Phospholipid Antibody
11%
Platelet Count
11%
Activated Partial Thromboplastin Time
10%
Disease
10%
Blood Clotting Time
9%
Thrombocytopenia
9%
Phospholipid
8%
Prevalence
7%
Highly Active Antiretroviral Therapy
7%
Communicable Disease
7%
Blood Lead Level
7%
Perinatal Mortality
7%
Maternal Mortality
7%
Medical Practice
7%
Vulnerable Population
7%
Autoimmune Hemolytic Anemia
7%
Blood Level
7%
Mortality Rate
7%
Leg Ulcer
7%
Iron
7%
Fibrinogen
5%
Anemia
5%
Immunology and Microbiology
Sickle Cell
39%
Prevalence
28%
Lupus Anticoagulant
23%
Human Immunodeficiency Virus
23%
Serotype
15%
Blood Transfusion
15%
Platelet Count
11%
Phospholipid Antibody
11%
Antimicrobial Resistance
9%
Blood Plasma
8%
Clotting Time
8%
HIV/AIDS
8%
Lead Blood Level
7%
Autoimmune Hemolytic Anemia
7%
Conjugate Vaccine
7%
Vein
7%
Vulnerable Population
7%
Third Trimester Pregnancy
7%
Immunology
7%
Multidrug Resistance
5%
Infectious Disease
5%